Showing codes C9067 (Gallium ga-68, dotatoc, diagnostic, 0.01 mci) — C9097 (Inj, faricimab-svoa, 0.1 mg)

C9067 - Gallium ga-68 dotatoc
Long description: Gallium ga-68, dotatoc, diagnostic, 0.01 mci
Code added date: 20201001.
Code effective date: 20240101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9068 - Copper cu-64, dotatate, dx
Long description: Copper cu-64, dotatate, diagnostic, 1 millicurie
Code added date: 20210101.
Code effective date: 20210401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9069 - Belantamab mafodontin-blmf
Long description: Injection, belantamab mafodontin-blmf, 0.5 mg
Code added date: 20210101.
Code effective date: 20210401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9070 - Injection, tafasitamab-cxix
Long description: Injection, tafasitamab-cxix, 2 mg
Code added date: 20210101.
Code effective date: 20210401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9071 - Injection, viltolarsen
Long description: Injection, viltolarsen, 10 mg
Code added date: 20210101.
Code effective date: 20210401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9072 - Inj, imm glob asceniv
Long description: Injection, immune globulin (asceniv), 500 mg
Code added date: 20210101.
Code effective date: 20210401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9073 - Brexucabtagene autoleucel ca
Long description: Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Code added date: 20210101.
Code effective date: 20210401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9074 - Injection, lumasiran
Long description: Injection, lumasiran, 0.5 mg
Code added date: 20210401.
Code effective date: 20210701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9075 - Injection, casimersen, 10 mg
Long description: Injection, casimersen, 10 mg
Code added date: 20210701.
Code effective date: 20211001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9076 - Lisocabtagene car pos t
Long description: Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Code added date: 20210701.
Code effective date: 20211001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9077 - Inj cabotegravir/rilpivirine
Long description: Injection, cabotegravir and rilpivirine, 2mg/3mg
Code added date: 20210701.
Code effective date: 20211001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9078 - Inj, trilaciclib, 1 mg
Long description: Injection, trilaciclib, 1 mg
Code added date: 20210701.
Code effective date: 20211001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9079 - Inj, evinacumab-dgnb, 5 mg
Long description: Injection, evinacumab-dgnb, 5 mg
Code added date: 20210701.
Code effective date: 20211001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9080 - Inj, melphalan flufen, 1 mg
Long description: Injection, melphalan flufenamide hydrochloride, 1 mg
Code added date: 20210701.
Code effective date: 20211001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9081 - Idecabtagene car pos t
Long description: Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Code added date: 20211001.
Code effective date: 20220101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9082 - Inj dostarlimab-gxly, 100 mg
Long description: Injection, dostarlimab-gxly, 100 mg
Code added date: 20211001.
Code effective date: 20220101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9083 - Inj, amivantamab-vmjw, 10 mg
Long description: Injection, amivantamab-vmjw, 10 mg
Code added date: 20211001.
Code effective date: 20220101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9084 - Loncastuximab-lpyl, 0.1 mg
Long description: Injection, loncastuximab tesirine-lpyl, 0.1 mg
Code added date: 20211001.
Code effective date: 20220401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9085 - Inj avalglucosid alfa-ngpt
Long description: Injection, avalglucosidase alfa-ngpt, 4 mg
Code added date: 20220101.
Code effective date: 20220401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9086 - Inj, anifrolumab-fnia
Long description: Injection, anifrolumab-fnia, 1 mg
Code added date: 20220101.
Code effective date: 20220401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9087 - Inj cyclophosphamd auromedic
Long description: Injection, cyclophosphamide, (auromedics), 10 mg
Code added date: 20220101.
Code effective date: 20220401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9088 - Instill, bupivac and meloxic
Long description: Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg
Code added date: 20220101.
Code effective date: 20220101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9089 - Bupivacaine implant, 1 mg
Long description: Bupivacaine, collagen-matrix implant, 1 mg
Code added date: 20220101.
Code effective date: 20220101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9090 - Plasminogen, human-tvmh 1 mg
Long description: Injection, plasminogen, human-tvmh, 1 mg
Code added date: 20220401.
Code effective date: 20220701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9091 - Sirolimus, protein-bound,1mg
Long description: Injection, sirolimus protein-bound particles, 1 mg
Code added date: 20220401.
Code effective date: 20220701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9092 - Inj., xipere, 1 mg
Long description: Injection, triamcinolone acetonide, suprachoroidal (xipere), 1 mg
Code added date: 20220401.
Code effective date: 20220701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9093 - Inj., susvimo, 0.1 mg
Long description: Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg
Code added date: 20220401.
Code effective date: 20220701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9094 - Inj, sutimlimab-jome, 10 mg
Long description: Inj, sutimlimab-jome, 10 mg
Code added date: 20220701.
Code effective date: 20221001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

C9095 - Inj, tebentafusp-tebn, 1 mcg
Long description: Inj, tebentafusp-tebn, 1 mcg
Code added date: 20220701.
Code effective date: 20221001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

C9096 - Inj, releuko, 1 mcg
Long description: Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
Code added date: 20220701.
Code effective date: 20221001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

C9097 - Inj, faricimab-svoa, 0.1 mg
Long description: Inj, faricimab-svoa, 0.1 mg
Code added date: 20220701.
Code effective date: 20221001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF